<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We reported a child of <z:e sem="disease" ids="C1096155" disease_type="Disease or Syndrome" abbrv="">macrophage activation syndrome</z:e> (MAS) associated with the course of systemic <z:hpo ids='HP_0005681'>juvenile rheumatoid arthritis</z:hpo> (sJRA) </plain></SENT>
<SENT sid="1" pm="."><plain>The clinical and laboratory findings in our case was ascribed to the overproduced inflammatory cytokines especially TNF-alpha by activated macrophages </plain></SENT>
<SENT sid="2" pm="."><plain>Moreover, macrophage-colony stimulating factor (M-CSF) was also elevated in the active phase of the disease, and decreased in the convalescent phase, indicating that M-CSF can be the most potent stimulator of macrophages to produce inflammatory cytokines </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="4031">Cyclosporine</z:chebi> A along with plasmaexchange and <z:chebi fb="0" ids="50858">corticosteroid</z:chebi>, instead of <z:chebi fb="0" ids="4911">VP16</z:chebi> or other immunosuppresive agents, was effecting in the management of this severe, life-threatening MAS </plain></SENT>
</text></document>